72 results
Page 2 of 4
424B5
gqz ugxnh042l07xiv2
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
oizcf
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
ja9m3q2x7z
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.1
tgfn8fu
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
2rmbf lwgx4bsv0lnzg
28 Aug 20
Prospectus supplement
4:31pm
8-K
EX-10.1
c8yz ndssxk
26 Jun 20
Departure of Directors or Certain Officers
4:06pm
425
73e2qbbtk ct46racq9
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-2.1
yomdg778 sa6v48
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
yxmy6
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
425
ztn mt57s46852r44cb
24 Jun 20
Business combination disclosure
4:03pm
425
re9 51rf6aa4
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.3
rzt3wud9yj2o2gj7sn
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.4
f68sd 6jn
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm